nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C8—Sorafenib—liver cancer	0.127	0.359	CbGbCtD
Candesartan—CYP2C9—Sorafenib—liver cancer	0.0889	0.25	CbGbCtD
Candesartan—ABCB1—Sorafenib—liver cancer	0.0862	0.243	CbGbCtD
Candesartan—ABCB1—Doxorubicin—liver cancer	0.0523	0.147	CbGbCtD
Candesartan—Bilirubin total increased—Epirubicin—liver cancer	0.0105	0.0385	CcSEcCtD
Candesartan—Bilirubin total increased—Doxorubicin—liver cancer	0.00968	0.0356	CcSEcCtD
Candesartan—Irbesartan—JUN—liver cancer	0.00777	0.428	CrCbGaD
Candesartan—Rhabdomyolysis—Sorafenib—liver cancer	0.00642	0.0236	CcSEcCtD
Candesartan—Blood bilirubin increased—Sorafenib—liver cancer	0.00601	0.0221	CcSEcCtD
Candesartan—Cardiac failure congestive—Sorafenib—liver cancer	0.00455	0.0167	CcSEcCtD
Candesartan—Pranlukast—TNF—liver cancer	0.00436	0.241	CrCbGaD
Candesartan—Kidney function abnormal—Epirubicin—liver cancer	0.00434	0.016	CcSEcCtD
Candesartan—Cardiac failure—Sorafenib—liver cancer	0.00423	0.0155	CcSEcCtD
Candesartan—Hyponatraemia—Sorafenib—liver cancer	0.00414	0.0152	CcSEcCtD
Candesartan—Kidney function abnormal—Doxorubicin—liver cancer	0.00402	0.0148	CcSEcCtD
Candesartan—Telmisartan—PPARG—liver cancer	0.00376	0.207	CrCbGaD
Candesartan—Transaminases increased—Epirubicin—liver cancer	0.00345	0.0127	CcSEcCtD
Candesartan—Serum creatinine increased—Epirubicin—liver cancer	0.00341	0.0126	CcSEcCtD
Candesartan—Neutropenia—Sorafenib—liver cancer	0.00333	0.0123	CcSEcCtD
Candesartan—Transaminases increased—Doxorubicin—liver cancer	0.00319	0.0117	CcSEcCtD
Candesartan—Serum creatinine increased—Doxorubicin—liver cancer	0.00316	0.0116	CcSEcCtD
Candesartan—Acute coronary syndrome—Sorafenib—liver cancer	0.00313	0.0115	CcSEcCtD
Candesartan—Renal failure—Sorafenib—liver cancer	0.00312	0.0115	CcSEcCtD
Candesartan—Myocardial infarction—Sorafenib—liver cancer	0.00312	0.0115	CcSEcCtD
Candesartan—Epistaxis—Sorafenib—liver cancer	0.003	0.011	CcSEcCtD
Candesartan—Haemoglobin—Sorafenib—liver cancer	0.00287	0.0105	CcSEcCtD
Candesartan—Haemorrhage—Sorafenib—liver cancer	0.00285	0.0105	CcSEcCtD
Candesartan—Urinary tract disorder—Sorafenib—liver cancer	0.00282	0.0104	CcSEcCtD
Candesartan—Albuminuria—Epirubicin—liver cancer	0.00281	0.0103	CcSEcCtD
Candesartan—Urethral disorder—Sorafenib—liver cancer	0.0028	0.0103	CcSEcCtD
Candesartan—Albuminuria—Doxorubicin—liver cancer	0.0026	0.00957	CcSEcCtD
Candesartan—Mental disorder—Sorafenib—liver cancer	0.0025	0.0092	CcSEcCtD
Candesartan—Malnutrition—Sorafenib—liver cancer	0.00248	0.00914	CcSEcCtD
Candesartan—Anaemia—Sorafenib—liver cancer	0.0023	0.00844	CcSEcCtD
Candesartan—Angioedema—Sorafenib—liver cancer	0.00227	0.00835	CcSEcCtD
Candesartan—Hyperuricaemia—Epirubicin—liver cancer	0.00226	0.00833	CcSEcCtD
Candesartan—Leukopenia—Sorafenib—liver cancer	0.00222	0.00818	CcSEcCtD
Candesartan—Blood bilirubin increased—Epirubicin—liver cancer	0.00222	0.00817	CcSEcCtD
Candesartan—Cough—Sorafenib—liver cancer	0.00217	0.00797	CcSEcCtD
Candesartan—Hypertension—Sorafenib—liver cancer	0.00214	0.00789	CcSEcCtD
Candesartan—Blood uric acid increased—Epirubicin—liver cancer	0.00214	0.00787	CcSEcCtD
Candesartan—Arthralgia—Sorafenib—liver cancer	0.00211	0.00778	CcSEcCtD
Candesartan—Myalgia—Sorafenib—liver cancer	0.00211	0.00778	CcSEcCtD
Candesartan—Hyperuricaemia—Doxorubicin—liver cancer	0.00209	0.0077	CcSEcCtD
Candesartan—Hyperkalaemia—Epirubicin—liver cancer	0.00206	0.00759	CcSEcCtD
Candesartan—Blood bilirubin increased—Doxorubicin—liver cancer	0.00205	0.00756	CcSEcCtD
Candesartan—Thrombocytopenia—Sorafenib—liver cancer	0.00198	0.0073	CcSEcCtD
Candesartan—Blood urea increased—Epirubicin—liver cancer	0.00198	0.00729	CcSEcCtD
Candesartan—Blood uric acid increased—Doxorubicin—liver cancer	0.00198	0.00728	CcSEcCtD
Candesartan—Hyperkalaemia—Doxorubicin—liver cancer	0.00191	0.00702	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00185	0.00679	CcSEcCtD
Candesartan—Blood urea increased—Doxorubicin—liver cancer	0.00183	0.00675	CcSEcCtD
Candesartan—Dyspnoea—Sorafenib—liver cancer	0.00181	0.00665	CcSEcCtD
Candesartan—Dyspepsia—Sorafenib—liver cancer	0.00178	0.00656	CcSEcCtD
Candesartan—Gastrointestinal disorder—Sorafenib—liver cancer	0.00175	0.00644	CcSEcCtD
Candesartan—Fatigue—Sorafenib—liver cancer	0.00175	0.00643	CcSEcCtD
Candesartan—Cardiac failure congestive—Epirubicin—liver cancer	0.00168	0.00618	CcSEcCtD
Candesartan—Gastrointestinal pain—Sorafenib—liver cancer	0.00166	0.0061	CcSEcCtD
Candesartan—Urticaria—Sorafenib—liver cancer	0.00161	0.00592	CcSEcCtD
Candesartan—Abdominal pain—Sorafenib—liver cancer	0.0016	0.00589	CcSEcCtD
Candesartan—Body temperature increased—Sorafenib—liver cancer	0.0016	0.00589	CcSEcCtD
Candesartan—Renal impairment—Epirubicin—liver cancer	0.0016	0.00589	CcSEcCtD
Candesartan—Cardiac failure—Epirubicin—liver cancer	0.00156	0.00575	CcSEcCtD
Candesartan—Cardiac failure congestive—Doxorubicin—liver cancer	0.00156	0.00572	CcSEcCtD
Candesartan—Hyponatraemia—Epirubicin—liver cancer	0.00153	0.00563	CcSEcCtD
Candesartan—Valsartan—ALB—liver cancer	0.00151	0.083	CrCbGaD
Candesartan—Renal impairment—Doxorubicin—liver cancer	0.00148	0.00545	CcSEcCtD
Candesartan—Asthenia—Sorafenib—liver cancer	0.00145	0.00535	CcSEcCtD
Candesartan—Cardiac failure—Doxorubicin—liver cancer	0.00145	0.00532	CcSEcCtD
Candesartan—Pruritus—Sorafenib—liver cancer	0.00143	0.00528	CcSEcCtD
Candesartan—Blood creatinine increased—Epirubicin—liver cancer	0.00143	0.00525	CcSEcCtD
Candesartan—Hyponatraemia—Doxorubicin—liver cancer	0.00142	0.00521	CcSEcCtD
Candesartan—Diarrhoea—Sorafenib—liver cancer	0.00139	0.0051	CcSEcCtD
Candesartan—Dizziness—Sorafenib—liver cancer	0.00134	0.00493	CcSEcCtD
Candesartan—Blood creatinine increased—Doxorubicin—liver cancer	0.00132	0.00486	CcSEcCtD
Candesartan—Vomiting—Sorafenib—liver cancer	0.00129	0.00474	CcSEcCtD
Candesartan—Angina pectoris—Epirubicin—liver cancer	0.00128	0.00472	CcSEcCtD
Candesartan—Rash—Sorafenib—liver cancer	0.00128	0.0047	CcSEcCtD
Candesartan—Dermatitis—Sorafenib—liver cancer	0.00128	0.0047	CcSEcCtD
Candesartan—Headache—Sorafenib—liver cancer	0.00127	0.00467	CcSEcCtD
Candesartan—Bronchitis—Epirubicin—liver cancer	0.00127	0.00466	CcSEcCtD
Candesartan—Neutropenia—Epirubicin—liver cancer	0.00123	0.00453	CcSEcCtD
Candesartan—Upper respiratory tract infection—Epirubicin—liver cancer	0.00122	0.0045	CcSEcCtD
Candesartan—Nausea—Sorafenib—liver cancer	0.0012	0.00443	CcSEcCtD
Candesartan—Hyperglycaemia—Epirubicin—liver cancer	0.00119	0.00437	CcSEcCtD
Candesartan—Angina pectoris—Doxorubicin—liver cancer	0.00119	0.00437	CcSEcCtD
Candesartan—Bronchitis—Doxorubicin—liver cancer	0.00117	0.00431	CcSEcCtD
Candesartan—Renal failure—Epirubicin—liver cancer	0.00115	0.00425	CcSEcCtD
Candesartan—Neutropenia—Doxorubicin—liver cancer	0.00114	0.00419	CcSEcCtD
Candesartan—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00113	0.00417	CcSEcCtD
Candesartan—Haematuria—Epirubicin—liver cancer	0.00112	0.00412	CcSEcCtD
Candesartan—Epistaxis—Epirubicin—liver cancer	0.00111	0.00408	CcSEcCtD
Candesartan—Sinusitis—Epirubicin—liver cancer	0.0011	0.00405	CcSEcCtD
Candesartan—Hyperglycaemia—Doxorubicin—liver cancer	0.0011	0.00404	CcSEcCtD
Candesartan—Agranulocytosis—Epirubicin—liver cancer	0.0011	0.00403	CcSEcCtD
Candesartan—Renal failure—Doxorubicin—liver cancer	0.00107	0.00393	CcSEcCtD
Candesartan—Haemoglobin—Epirubicin—liver cancer	0.00106	0.0039	CcSEcCtD
Candesartan—Rhinitis—Epirubicin—liver cancer	0.00106	0.00389	CcSEcCtD
Candesartan—Haemorrhage—Epirubicin—liver cancer	0.00105	0.00388	CcSEcCtD
Candesartan—Hepatitis—Epirubicin—liver cancer	0.00105	0.00388	CcSEcCtD
Candesartan—Pharyngitis—Epirubicin—liver cancer	0.00105	0.00385	CcSEcCtD
Candesartan—Urinary tract disorder—Epirubicin—liver cancer	0.00104	0.00383	CcSEcCtD
Candesartan—Oedema peripheral—Epirubicin—liver cancer	0.00104	0.00382	CcSEcCtD
Candesartan—Haematuria—Doxorubicin—liver cancer	0.00104	0.00381	CcSEcCtD
Candesartan—Urethral disorder—Epirubicin—liver cancer	0.00103	0.0038	CcSEcCtD
Candesartan—Epistaxis—Doxorubicin—liver cancer	0.00103	0.00377	CcSEcCtD
Candesartan—Sinusitis—Doxorubicin—liver cancer	0.00102	0.00375	CcSEcCtD
Candesartan—Agranulocytosis—Doxorubicin—liver cancer	0.00101	0.00373	CcSEcCtD
Candesartan—Haemoglobin—Doxorubicin—liver cancer	0.000981	0.00361	CcSEcCtD
Candesartan—Rhinitis—Doxorubicin—liver cancer	0.000978	0.0036	CcSEcCtD
Candesartan—Haemorrhage—Doxorubicin—liver cancer	0.000976	0.00359	CcSEcCtD
Candesartan—Hepatitis—Doxorubicin—liver cancer	0.000976	0.00359	CcSEcCtD
Candesartan—Pharyngitis—Doxorubicin—liver cancer	0.000968	0.00356	CcSEcCtD
Candesartan—Urinary tract disorder—Doxorubicin—liver cancer	0.000963	0.00354	CcSEcCtD
Candesartan—Oedema peripheral—Doxorubicin—liver cancer	0.000961	0.00354	CcSEcCtD
Candesartan—Urethral disorder—Doxorubicin—liver cancer	0.000956	0.00352	CcSEcCtD
Candesartan—Mental disorder—Epirubicin—liver cancer	0.000924	0.0034	CcSEcCtD
Candesartan—Malnutrition—Epirubicin—liver cancer	0.000918	0.00338	CcSEcCtD
Candesartan—Back pain—Epirubicin—liver cancer	0.000888	0.00327	CcSEcCtD
Candesartan—Mental disorder—Doxorubicin—liver cancer	0.000855	0.00314	CcSEcCtD
Candesartan—Malnutrition—Doxorubicin—liver cancer	0.000849	0.00312	CcSEcCtD
Candesartan—Anaemia—Epirubicin—liver cancer	0.000848	0.00312	CcSEcCtD
Candesartan—Vertigo—Epirubicin—liver cancer	0.000825	0.00303	CcSEcCtD
Candesartan—Leukopenia—Epirubicin—liver cancer	0.000822	0.00302	CcSEcCtD
Candesartan—Back pain—Doxorubicin—liver cancer	0.000822	0.00302	CcSEcCtD
Candesartan—Palpitations—Epirubicin—liver cancer	0.000811	0.00298	CcSEcCtD
Candesartan—Cough—Epirubicin—liver cancer	0.000801	0.00295	CcSEcCtD
Candesartan—Hypertension—Epirubicin—liver cancer	0.000792	0.00292	CcSEcCtD
Candesartan—Anaemia—Doxorubicin—liver cancer	0.000785	0.00289	CcSEcCtD
Candesartan—Chest pain—Epirubicin—liver cancer	0.000781	0.00287	CcSEcCtD
Candesartan—Myalgia—Epirubicin—liver cancer	0.000781	0.00287	CcSEcCtD
Candesartan—Arthralgia—Epirubicin—liver cancer	0.000781	0.00287	CcSEcCtD
Candesartan—Anxiety—Epirubicin—liver cancer	0.000779	0.00286	CcSEcCtD
Candesartan—Vertigo—Doxorubicin—liver cancer	0.000763	0.00281	CcSEcCtD
Candesartan—Leukopenia—Doxorubicin—liver cancer	0.00076	0.0028	CcSEcCtD
Candesartan—Palpitations—Doxorubicin—liver cancer	0.000751	0.00276	CcSEcCtD
Candesartan—Cough—Doxorubicin—liver cancer	0.000741	0.00273	CcSEcCtD
Candesartan—Losartan—ALB—liver cancer	0.000735	0.0405	CrCbGaD
Candesartan—Thrombocytopenia—Epirubicin—liver cancer	0.000733	0.0027	CcSEcCtD
Candesartan—Hypertension—Doxorubicin—liver cancer	0.000733	0.0027	CcSEcCtD
Candesartan—Tachycardia—Epirubicin—liver cancer	0.000731	0.00269	CcSEcCtD
Candesartan—Hyperhidrosis—Epirubicin—liver cancer	0.000724	0.00266	CcSEcCtD
Candesartan—Arthralgia—Doxorubicin—liver cancer	0.000723	0.00266	CcSEcCtD
Candesartan—Chest pain—Doxorubicin—liver cancer	0.000723	0.00266	CcSEcCtD
Candesartan—Myalgia—Doxorubicin—liver cancer	0.000723	0.00266	CcSEcCtD
Candesartan—Anxiety—Doxorubicin—liver cancer	0.000721	0.00265	CcSEcCtD
Candesartan—Hypotension—Epirubicin—liver cancer	0.0007	0.00258	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000682	0.00251	CcSEcCtD
Candesartan—Thrombocytopenia—Doxorubicin—liver cancer	0.000679	0.0025	CcSEcCtD
Candesartan—Tachycardia—Doxorubicin—liver cancer	0.000676	0.00249	CcSEcCtD
Candesartan—Paraesthesia—Epirubicin—liver cancer	0.000673	0.00247	CcSEcCtD
Candesartan—Hyperhidrosis—Doxorubicin—liver cancer	0.00067	0.00247	CcSEcCtD
Candesartan—Dyspnoea—Epirubicin—liver cancer	0.000668	0.00246	CcSEcCtD
Candesartan—Somnolence—Epirubicin—liver cancer	0.000666	0.00245	CcSEcCtD
Candesartan—Dyspepsia—Epirubicin—liver cancer	0.000659	0.00243	CcSEcCtD
Candesartan—Hypotension—Doxorubicin—liver cancer	0.000648	0.00238	CcSEcCtD
Candesartan—Gastrointestinal disorder—Epirubicin—liver cancer	0.000647	0.00238	CcSEcCtD
Candesartan—Fatigue—Epirubicin—liver cancer	0.000646	0.00238	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000631	0.00232	CcSEcCtD
Candesartan—Paraesthesia—Doxorubicin—liver cancer	0.000622	0.00229	CcSEcCtD
Candesartan—Dyspnoea—Doxorubicin—liver cancer	0.000618	0.00227	CcSEcCtD
Candesartan—Somnolence—Doxorubicin—liver cancer	0.000616	0.00227	CcSEcCtD
Candesartan—Gastrointestinal pain—Epirubicin—liver cancer	0.000613	0.00225	CcSEcCtD
Candesartan—Dyspepsia—Doxorubicin—liver cancer	0.00061	0.00224	CcSEcCtD
Candesartan—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000598	0.0022	CcSEcCtD
Candesartan—Fatigue—Doxorubicin—liver cancer	0.000598	0.0022	CcSEcCtD
Candesartan—Urticaria—Epirubicin—liver cancer	0.000595	0.00219	CcSEcCtD
Candesartan—Body temperature increased—Epirubicin—liver cancer	0.000592	0.00218	CcSEcCtD
Candesartan—Abdominal pain—Epirubicin—liver cancer	0.000592	0.00218	CcSEcCtD
Candesartan—Gastrointestinal pain—Doxorubicin—liver cancer	0.000567	0.00209	CcSEcCtD
Candesartan—Urticaria—Doxorubicin—liver cancer	0.000551	0.00203	CcSEcCtD
Candesartan—Abdominal pain—Doxorubicin—liver cancer	0.000548	0.00202	CcSEcCtD
Candesartan—Body temperature increased—Doxorubicin—liver cancer	0.000548	0.00202	CcSEcCtD
Candesartan—Asthenia—Epirubicin—liver cancer	0.000537	0.00198	CcSEcCtD
Candesartan—Pruritus—Epirubicin—liver cancer	0.00053	0.00195	CcSEcCtD
Candesartan—Diarrhoea—Epirubicin—liver cancer	0.000513	0.00189	CcSEcCtD
Candesartan—Asthenia—Doxorubicin—liver cancer	0.000497	0.00183	CcSEcCtD
Candesartan—Dizziness—Epirubicin—liver cancer	0.000495	0.00182	CcSEcCtD
Candesartan—Pruritus—Doxorubicin—liver cancer	0.00049	0.0018	CcSEcCtD
Candesartan—Vomiting—Epirubicin—liver cancer	0.000476	0.00175	CcSEcCtD
Candesartan—Diarrhoea—Doxorubicin—liver cancer	0.000474	0.00174	CcSEcCtD
Candesartan—Rash—Epirubicin—liver cancer	0.000472	0.00174	CcSEcCtD
Candesartan—Dermatitis—Epirubicin—liver cancer	0.000472	0.00174	CcSEcCtD
Candesartan—Headache—Epirubicin—liver cancer	0.000469	0.00173	CcSEcCtD
Candesartan—Dizziness—Doxorubicin—liver cancer	0.000458	0.00169	CcSEcCtD
Candesartan—Nausea—Epirubicin—liver cancer	0.000445	0.00164	CcSEcCtD
Candesartan—Vomiting—Doxorubicin—liver cancer	0.000441	0.00162	CcSEcCtD
Candesartan—Rash—Doxorubicin—liver cancer	0.000437	0.00161	CcSEcCtD
Candesartan—Dermatitis—Doxorubicin—liver cancer	0.000437	0.00161	CcSEcCtD
Candesartan—Headache—Doxorubicin—liver cancer	0.000434	0.0016	CcSEcCtD
Candesartan—Nausea—Doxorubicin—liver cancer	0.000412	0.00151	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—TNF—liver cancer	0.000145	0.000408	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—UGDH—liver cancer	0.000145	0.000408	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—F2—liver cancer	0.000144	0.000405	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PSMA4—liver cancer	0.000144	0.000404	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PSMD10—liver cancer	0.000144	0.000404	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.00014	0.000393	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CG—liver cancer	0.000138	0.000388	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—EPT1—liver cancer	0.000136	0.000384	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYCS—liver cancer	0.000136	0.000383	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000136	0.000382	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—UGDH—liver cancer	0.000135	0.000381	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTA4—liver cancer	0.000135	0.000381	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GOT1—liver cancer	0.000134	0.000376	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GGT1—liver cancer	0.000134	0.000376	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000132	0.000372	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTA2—liver cancer	0.000132	0.000371	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—F2—liver cancer	0.000131	0.000368	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TAT—liver cancer	0.000129	0.000364	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—EPT1—liver cancer	0.000127	0.000358	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTA1—liver cancer	0.000127	0.000358	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NAT2—liver cancer	0.000126	0.000354	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CG—liver cancer	0.000125	0.000352	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	0.000125	0.000351	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CD—liver cancer	0.000121	0.000341	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000121	0.00034	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TAT—liver cancer	0.000121	0.00034	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALDOB—liver cancer	0.000121	0.000339	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTP1—liver cancer	0.00012	0.000338	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000119	0.000334	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—HMOX1—liver cancer	0.000118	0.000333	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CRABP1—liver cancer	0.000115	0.000324	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PRKCE—liver cancer	0.000111	0.000313	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTM1—liver cancer	0.00011	0.00031	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CD—liver cancer	0.00011	0.00031	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.00011	0.000308	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000109	0.000307	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CB—liver cancer	0.000106	0.000297	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF2—liver cancer	0.000105	0.000297	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP1A1—liver cancer	0.000105	0.000294	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000104	0.000292	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GLUL—liver cancer	0.000101	0.000284	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CPT1B—liver cancer	0.000101	0.000284	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HPGDS—liver cancer	0.000101	0.000283	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.0001	0.000283	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.99e-05	0.000281	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CSF2—liver cancer	9.84e-05	0.000277	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	9.83e-05	0.000277	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—RAF1—liver cancer	9.82e-05	0.000277	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—MTHFR—liver cancer	9.74e-05	0.000274	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NR1H4—liver cancer	9.72e-05	0.000274	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—H2AFX—liver cancer	9.7e-05	0.000273	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—liver cancer	9.7e-05	0.000273	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CB—liver cancer	9.59e-05	0.00027	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	9.57e-05	0.00027	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARA—liver cancer	9.56e-05	0.000269	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	9.55e-05	0.000269	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTA3—liver cancer	9.55e-05	0.000269	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	9.48e-05	0.000267	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	9.26e-05	0.000261	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	9.21e-05	0.000259	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.1e-05	0.000256	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	9.04e-05	0.000254	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.99e-05	0.000253	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PSMD10—liver cancer	8.96e-05	0.000252	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PSMA4—liver cancer	8.96e-05	0.000252	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	8.88e-05	0.00025	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—liver cancer	8.81e-05	0.000248	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CPT1B—liver cancer	8.78e-05	0.000247	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GLUL—liver cancer	8.78e-05	0.000247	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TERT—liver cancer	8.77e-05	0.000247	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTA4—liver cancer	8.74e-05	0.000246	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GOT2—liver cancer	8.71e-05	0.000245	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	8.54e-05	0.00024	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTA2—liver cancer	8.51e-05	0.00024	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NR1H4—liver cancer	8.46e-05	0.000238	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	8.34e-05	0.000235	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTA3—liver cancer	8.32e-05	0.000234	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTA1—liver cancer	8.21e-05	0.000231	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CPT1B—liver cancer	8.2e-05	0.000231	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GLUL—liver cancer	8.2e-05	0.000231	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP2E1—liver cancer	8.19e-05	0.000231	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CG—liver cancer	8.19e-05	0.000231	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NAT2—liver cancer	8.12e-05	0.000229	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KDR—liver cancer	8.03e-05	0.000226	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	8.01e-05	0.000225	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK14—liver cancer	7.97e-05	0.000224	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.93e-05	0.000223	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NR1H4—liver cancer	7.91e-05	0.000223	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—liver cancer	7.9e-05	0.000222	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ESR1—liver cancer	7.82e-05	0.00022	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.81e-05	0.00022	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALDOB—liver cancer	7.79e-05	0.000219	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTA3—liver cancer	7.77e-05	0.000219	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—F2—liver cancer	7.72e-05	0.000218	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	7.68e-05	0.000216	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYCS—liver cancer	7.67e-05	0.000216	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	7.66e-05	0.000216	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTA4—liver cancer	7.61e-05	0.000214	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GGT1—liver cancer	7.52e-05	0.000212	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GOT1—liver cancer	7.52e-05	0.000212	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CRABP1—liver cancer	7.43e-05	0.000209	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTA2—liver cancer	7.42e-05	0.000209	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APC—liver cancer	7.39e-05	0.000208	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CG—liver cancer	7.39e-05	0.000208	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CD—liver cancer	7.2e-05	0.000203	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTA1—liver cancer	7.16e-05	0.000201	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	7.15e-05	0.000201	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTA4—liver cancer	7.11e-05	0.0002	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—liver cancer	7.1e-05	0.0002	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	7.09e-05	0.0002	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NAT2—liver cancer	7.08e-05	0.000199	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.95e-05	0.000196	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BRAF—liver cancer	6.95e-05	0.000196	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTA2—liver cancer	6.93e-05	0.000195	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALDOB—liver cancer	6.78e-05	0.000191	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTP1—liver cancer	6.76e-05	0.00019	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.69e-05	0.000188	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTA1—liver cancer	6.68e-05	0.000188	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMOX1—liver cancer	6.66e-05	0.000188	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NAT2—liver cancer	6.61e-05	0.000186	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	6.52e-05	0.000184	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CD—liver cancer	6.5e-05	0.000183	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HPGDS—liver cancer	6.49e-05	0.000183	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CRABP1—liver cancer	6.47e-05	0.000182	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	6.47e-05	0.000182	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.45e-05	0.000182	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CA—liver cancer	6.44e-05	0.000181	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SERPINE1—liver cancer	6.43e-05	0.000181	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—KRAS—liver cancer	6.36e-05	0.000179	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.36e-05	0.000179	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALDOB—liver cancer	6.34e-05	0.000178	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	6.31e-05	0.000178	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CB—liver cancer	6.27e-05	0.000177	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—liver cancer	6.21e-05	0.000175	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CRABP1—liver cancer	6.05e-05	0.00017	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP1A1—liver cancer	5.89e-05	0.000166	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.88e-05	0.000166	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CA—liver cancer	5.85e-05	0.000165	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.8e-05	0.000163	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RAF1—liver cancer	5.8e-05	0.000163	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PSMA4—liver cancer	5.79e-05	0.000163	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PSMD10—liver cancer	5.79e-05	0.000163	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MTOR—liver cancer	5.66e-05	0.00016	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CB—liver cancer	5.66e-05	0.00016	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HPGDS—liver cancer	5.66e-05	0.000159	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GOT2—liver cancer	5.63e-05	0.000159	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—liver cancer	5.49e-05	0.000155	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.44e-05	0.000153	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—HRAS—liver cancer	5.41e-05	0.000152	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARA—liver cancer	5.38e-05	0.000152	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	5.32e-05	0.00015	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1B—liver cancer	5.32e-05	0.00015	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2E1—liver cancer	5.29e-05	0.000149	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HPGDS—liver cancer	5.28e-05	0.000149	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—liver cancer	5.26e-05	0.000148	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.25e-05	0.000148	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CASP3—liver cancer	5.21e-05	0.000147	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—liver cancer	5.2e-05	0.000146	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—liver cancer	5.18e-05	0.000146	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.12e-05	0.000144	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—liver cancer	5.07e-05	0.000143	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JUN—liver cancer	5.06e-05	0.000143	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PSMA4—liver cancer	5.04e-05	0.000142	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PSMD10—liver cancer	5.04e-05	0.000142	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CTNNB1—liver cancer	5.02e-05	0.000141	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYCS—liver cancer	4.95e-05	0.000139	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—liver cancer	4.92e-05	0.000139	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1A—liver cancer	4.91e-05	0.000138	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GOT2—liver cancer	4.9e-05	0.000138	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GOT1—liver cancer	4.86e-05	0.000137	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GGT1—liver cancer	4.86e-05	0.000137	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.84e-05	0.000136	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	4.81e-05	0.000135	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK8—liver cancer	4.79e-05	0.000135	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.78e-05	0.000135	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—liver cancer	4.78e-05	0.000134	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.72e-05	0.000133	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PSMD10—liver cancer	4.71e-05	0.000133	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PSMA4—liver cancer	4.71e-05	0.000133	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2E1—liver cancer	4.61e-05	0.00013	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CG—liver cancer	4.61e-05	0.00013	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GOT2—liver cancer	4.58e-05	0.000129	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—liver cancer	4.45e-05	0.000125	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—liver cancer	4.42e-05	0.000124	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—liver cancer	4.38e-05	0.000123	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTP1—liver cancer	4.36e-05	0.000123	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	4.35e-05	0.000122	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYCS—liver cancer	4.31e-05	0.000121	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP2E1—liver cancer	4.31e-05	0.000121	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMOX1—liver cancer	4.3e-05	0.000121	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GGT1—liver cancer	4.23e-05	0.000119	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GOT1—liver cancer	4.23e-05	0.000119	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.17e-05	0.000117	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—liver cancer	4.07e-05	0.000115	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—liver cancer	4.06e-05	0.000114	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CD—liver cancer	4.05e-05	0.000114	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYCS—liver cancer	4.03e-05	0.000113	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—liver cancer	4.01e-05	0.000113	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—liver cancer	4e-05	0.000113	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GOT1—liver cancer	3.95e-05	0.000111	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GGT1—liver cancer	3.95e-05	0.000111	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CA—liver cancer	3.82e-05	0.000108	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTP1—liver cancer	3.8e-05	0.000107	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP1A1—liver cancer	3.8e-05	0.000107	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KRAS—liver cancer	3.76e-05	0.000106	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMOX1—liver cancer	3.75e-05	0.000106	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTP1—liver cancer	3.55e-05	0.0001	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—liver cancer	3.54e-05	9.98e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CB—liver cancer	3.53e-05	9.95e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMOX1—liver cancer	3.5e-05	9.87e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—liver cancer	3.49e-05	9.84e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARA—liver cancer	3.48e-05	9.79e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CA—liver cancer	3.45e-05	9.72e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—liver cancer	3.34e-05	9.41e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP1A1—liver cancer	3.31e-05	9.33e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—liver cancer	3.26e-05	9.19e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HRAS—liver cancer	3.19e-05	9e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.12e-05	8.8e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—liver cancer	3.12e-05	8.8e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP1A1—liver cancer	3.09e-05	8.71e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—liver cancer	3.09e-05	8.7e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—liver cancer	3.06e-05	8.61e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARA—liver cancer	3.03e-05	8.53e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CG—liver cancer	2.98e-05	8.39e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—liver cancer	2.89e-05	8.12e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—liver cancer	2.87e-05	8.09e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARA—liver cancer	2.83e-05	7.97e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—liver cancer	2.82e-05	7.94e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CD—liver cancer	2.62e-05	7.37e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CG—liver cancer	2.59e-05	7.31e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—liver cancer	2.58e-05	7.28e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.54e-05	7.16e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—liver cancer	2.5e-05	7.05e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CG—liver cancer	2.42e-05	6.83e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—liver cancer	2.34e-05	6.59e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CB—liver cancer	2.28e-05	6.43e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CD—liver cancer	2.28e-05	6.42e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—liver cancer	2.25e-05	6.34e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CA—liver cancer	2.15e-05	6.06e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CD—liver cancer	2.13e-05	6e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—liver cancer	2.1e-05	5.92e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CB—liver cancer	1.99e-05	5.6e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CB—liver cancer	1.86e-05	5.23e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—liver cancer	1.76e-05	4.95e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CA—liver cancer	1.39e-05	3.92e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CA—liver cancer	1.21e-05	3.41e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—liver cancer	1.14e-05	3.2e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CA—liver cancer	1.13e-05	3.19e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—liver cancer	9.9e-06	2.79e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—liver cancer	9.25e-06	2.6e-05	CbGpPWpGaD
